Table 1.
Correlation and prognostic value of deiodinase/ sodium iodide symporter expression with gender of gastric cancer patients
| DIOs/NIS | Gender | Cases | HR (95% CI) | P |
|---|---|---|---|---|
| NIS | Male | 545 | 1.85 (1.5-2.29) | 9.2e-09 |
| Female | 236 | 1.99 (1.4-2.83) | 9.9e-05 | |
| DIO1 | Male | 545 | 1.42 (1.15-1.76) | 0.0012 |
| Female | 236 | 1.96 (1.36-2.84) | 0.00028 | |
| DIO2 | Male | 545 | 1.25 (0.99-1.59) | 0.065 |
| Female | 236 | 1.96 (1.35-2.84) | 0.00031 | |
| DIO3 | Male | 545 | 1.62 (1.38-2.04) | 4.5e-05 |
| Female | 236 | 2.19 (1.52-3.16) | 1.7e-05 |
NIS: Sodium iodide symporter; CI: Confidence interval; HR: Hazard ratio; DIOs: Deiodinases